Download Reports Upload prescription

Vaccinations

  • Rabies Vaccine-Rabivax S

    Rated 0 out of 5

    Indication:
    RABIVAX-S is indicated for the prevention of rabies in children and adults. It can be used for pre-exposure and post-exposure prophylaxis.

    Route of Administration:

    • Intramuscular (IM)
    • Intradermal (ID)

    Immunization Schedule:

    Pre-exposure Prophylaxis (High-risk populations):

    • Intramuscular: 1 ml on Days 0, 7, and 21/28.
    • Intradermal: 0.1 ml on Days 0, 7, and 21/28.

    Post-exposure Prophylaxis (Unimmunized individuals):

    • Intramuscular: 1 ml on Days 0, 3, 7, 14, and 28.
    • Intradermal: 0.1 ml on Days 0, 3, 7, and 28.

    Post-exposure (Previously Immunized):

    • Single Dose on Days 0 and 3 (IM: 1 ml or ID: 0.1 ml).

  • Pneumococcal Vaccine-Prevnar 13

    Rated 0 out of 5

    Indication: For active immunization to prevent invasive disease, pneumonia, and otitis media caused by 13 strains of Streptococcus pneumoniae. Recommended for infants, young children, and individuals at increased risk due to health conditions, as well as adults aged 50 years and older.
    Route: Administered as an intramuscular injection, typically in the anterolateral aspect of the thigh for infants and the deltoid muscle of the upper arm for older children and adults.
    Immunization Schedule: For infants, a primary series of 3 doses at 6 weeks, 10 weeks, and 14 weeks of age, followed by a booster dose at 12-15 months. For unvaccinated older children and adults, the schedule varies based on age and risk factors, typically as a single dose or a catch-up schedule.

  • TDaP Vaccine-Boostrix

    Rated 0 out of 5

    Indication: For active immunization against tetanus, diphtheria, and pertussis (whooping cough) in individuals aged 10 years and older.
    Route: Administered as an intramuscular injection, typically in the upper arm.
    Immunization Schedule: Given as a single booster dose, with additional booster doses as recommended by a healthcare provider for continued protection.

  • MMR Vaccine-Tresivac PFS

    Rated 0 out of 5

    Indication: For active immunization against measles, mumps, and rubella in infants, children, adolescents, and young adults at risk.
    Route: Administered as a subcutaneous injection.
    Immunization Schedule: First dose at 9 months, second dose between 15-18 months, and third dose between 4-6 years of age.

  • HPV Vaccine-Gardasil 9

    Rated 0 out of 5
    ₹5,500.00

    Indication: Protects against cancers and diseases caused by nine types of human papillomavirus (HPV), including cervical, vulvar, vaginal, anal cancers, and certain head and neck cancers.
    Age: Approved for use in individuals aged 9 through 45 years.
    Route: Administered as an intramuscular injection, typically in the upper arm muscle.

  • Hepatitis B Vaccine-GeneVac-B®

    Rated 0 out of 5
    ₹100.00

    Indication: GeneVac-B® is used for the prevention of Hepatitis B infection in individuals at risk of exposure to the Hepatitis B virus (HBV), including healthcare personnel, travelers, and newborns of HBV-infected mothers.

    Age: Recommended for all individuals from birth onwards, including neonates, children, adolescents, and adults.

    Route of Administration: Administered as an intramuscular injection, typically in the deltoid muscle for adults and children, and in the thigh for neonates and infants.

  • Flu Vaccine-Influvac Tetra

    Rated 0 out of 5
    ₹2,500.00
    • Indication: Prevention of influenza in adults and children, especially at-risk groups.
    • Age: For individuals 6 months and older.
    • Route: Intramuscular injection (thigh for children 6-35 months, deltoid for those 36 months+)